Quince Therapeutics Inc
NASDAQ:QNCX
Other Pre-Announcement
Quince Therapeutics Provides Pipeline Update And Business Outlook For 2023
Published: 01/30/2023 22:42 GMT
Quince Therapeutics Inc (QNCX) - Quince Therapeutics Provides Pipeline Update and Business Outlook for 2023.
Quince Therapeutics Provides Pipeline Update and Business Outlook for 2023.
Quince Therapeutics - Strong Cash Position of Approximately $94 Million in Cash, Equivalents, and Marketable Securities As of December 31, 2022.
Quince Therapeutics - Cash Runway to Support Pipeline Expansion Through In-licensing and Acquisition Into at Least 2028.
Quince Therapeutics Provides Pipeline Update and Business Outlook for 2023.
Quince Therapeutics - Strong Cash Position of Approximately $94 Million in Cash, Equivalents, and Marketable Securities As of December 31, 2022.
Quince Therapeutics - Cash Runway to Support Pipeline Expansion Through In-licensing and Acquisition Into at Least 2028.